Description: Genolution Inc. manufactures and sells IVD products in South Korea and internationally. Its products are primarily focused on molecular diagnostics, ribonucleic acid interference (RNAi) services, and dsRNA research for the prevention of breeding and extermination. The company offers Nextractor, an automatic extraction system for isolation of DNA or RNA from various samples; and FFPE, whole blood, buccal swab, RV, TB/NTM, STD, HPV, HBV, and CMV/EBV extraction kits, as well as rice, plant, and cell extraction kits. It also provides siRNA/shRNA synthesis service to inhibit gene expression and other gene related services; and long dsRNA synthesis service to inhibit gene expression by injecting RNA into various living organisms. The company was founded in 2006 and is based in Seoul, South Korea.
Home Page: www.genolution1.com
Building A
Seoul,
05836
South Korea
Phone:
82 2 449 8670
Officers
| Name | Title |
|---|---|
| Ki-Ok Kim | Chief Executive Officer |
Exchange: KQ
Country: KR : Korea (Republic of)
Currency: Korean Won (₩)
| GIC Sector: | Health Care |
|---|---|
| GIC Group: | Pharmaceuticals, Biotechnology & Life Sciences |
| GIC Industry: | Biotechnology |
| GIC Sub-Industry: | Biotechnology |
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 0.4878 |
| Price-to-Sales TTM: | 3.6798 |
| IPO Date: | |
| Fiscal Year End: | December |
| Full Time Employees: | 0 |